1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY SOFTWARE
5.1. Introduction
5.2. Standalone Software
5.3. Integrated Software
6. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY IMAGING MODALITY
6.1. Introduction
6.2. X-Ray Imaging
6.3. Magnetic Resonance Imaging (MRI)
6.4. Ultraound Imaging
6.5. Computerised Tomography (CT) Scannig
6.6. Nuclear Imaging
6.7. Others
7. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic Centers
7.4. Others
8. GLOBAL MEDICAL/DIAGNOSTIC IMAGING MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. General Electric Healthcare
10.2. Koninklijke Philips N.V.
10.3. Siemens AG
10.4. Shimadzu Corporation
10.5. Canon Medical Systems Corporation (Canon)
10.6. Carestream Health
10.7. Esaote SpA
10.8. Samsung Healthcare (Samsung)
10.9. Fujifilm Corporation
10.10. Mindray Medical International Limited
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key Benefits for the Stakeholders
11.5. Research Methodology
11.6. Abbreviations